ISLAMABAD: In a significant development, Pakistan and China have formalized multiple agreements totaling $440 million in the pharmaceutical sector. The deals were sealed during a Pakistan-China Business-to-Business investment conference held today in Islamabad, bringing together Pakistani and Chinese pharmaceutical companies.
Prime Minister Shehbaz Sharif, addressing the gathering, expressed optimism that these agreements will soon lead to tangible projects and effective implementation. He described the collaboration as a crucial milestone in advancing the China-Pakistan Economic Corridor (CPEC) 2.0 initiative. The Prime Minister highlighted the strong Chinese participation, with around 300 delegates present, signifying the deepening commitment of both nations toward expanding economic and commercial ties.
Shehbaz Sharif emphasized the importance of the pharmaceutical partnership, noting that joint efforts could boost the production of vital medicines and vaccines, enhance research and development, and position Pakistan as a regional hub for pharmaceutical exports.
Commenting on regional challenges, the Prime Minister acknowledged the disruptions caused by ongoing crises but reaffirmed Pakistan’s role in fostering dialogue, citing its efforts in mediating between the United States and Iran. He also reiterated Pakistan’s dedication to ensuring the safety of Chinese nationals working in the country, calling them “guests and brothers,” and pledged that their security remains a top priority.
In a separate briefing, Minister for National Health Services Mustafa Kamal expressed confidence that the agreements would generate employment, facilitate technology transfer, and open new markets for Pakistan.
Haroon Akhtar Khan, Special Assistant to the Prime Minister on Industries and Production, added that Pakistan’s macro-economic stability paves the way for the country to emerge as a manufacturing hub.
